NDAC’s Wood To Join Private Rx Investment Firm
This article was originally published in The Pink Sheet Daily
Nonprescription Drugs Advisory Committee Chair Alastair Wood will join Symphony Capital, which specializes in biopharmaceutical investments.
You may also be interested in...
Infusion of venture capital will allow Lexicon to delay commercialization partnerships until its small molecule pipeline is more mature, firm says.
Energizer Holdings will gain Banana Boat and Hawaiian Tropic - the No. 2- and No. 4-selling sun- care brands, respectively - through its $1.9 billion purchase of Playtex Products, the companies announce July 12